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Abstract Previous studies have shown that lowering the 
GABAergic activity in the sub-pallidal area (SP) in the 
cat results in the display of oro-facial dyskinesia (OFD). 
There exists an intense, mutual anatomical connection 
between the SP and the subthalamic nucleus and the 
adjoining lateral hypothalamic area (STH). The pre­
sent study investigated whether the STH is also involved 
in OFD. Once this turned out to be true (see below), 
it was investigated whether the SP-specific OFD is fun- 
neled via the STH, or vice versa. Bilateral injections of 
low doses (50-250 ng) of picrotoxin, a non-competi­
tive GABA antagonist, into the STH were found 
to elicit OFD, This effect which was quantified in 
terms of numbers of tongue protrusions, was dose- 
dependent: a bell-shaped dose-response was found 
(50-500 ng). The OFD elicited by the most effective 
dose of picrotoxin (250 ng) was significantly antago­
nized by muscimol, a specific GABAa agonist, in a dose 
(50 ng) which itself was ineffective, indicating GABA 
specificity In addition, it was found that OFD elicited 
by local injections of picrotoxin (250 ng) into the STH 
was significantly attenuated by SP injections of the 
broad spectrum glutamate antagonist kynurenic acid 
in a dose (1000 ng) which itself was ineffective, but not 
by muscimol (100 ng), indicating that the STH-elicited 
OFD needs an intact and functioning glutaminergic, 
but not GABAergic, transmission process in the SP for 
its expression. Finally, it was found that OFD elicited 
by picrotoxin injections (500 ng) into the SP was 
significantly attenuated by muscimol injections (50 ng) 
into the STH, indicating that the SP-elicited OFD 
needs an intact and functioning GABAergic transmis­
sion process in the STH for its expression.
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Introduction
Oro-facial dyskinesia (OFD) is a syndrome of abnor­
mal involuntary movements of the oral and facial mus­
cles, It can occur in a variety of medicated and 
unmedicated subjects, but is predominantly present in 
patients chronically treated with antipsychotic or 
antiparkinson drugs (Schonecker 1957; for review: 
Waddington 1989). It has been hypothesized that OFD 
is due, at least in part, to alterations in dopaminergic 
systems (Klawans et al. 1980), although it is generally 
accepted now that it cannot simply reflect supersensi­
tivity of dopamine receptors (Waddington 1989). 
GABA has also been suggested to play a crucial role 
in this syndrome (Fibiger and Lloyd 1984). However, 
the underlying neuronal mechanisms of QFD are still 
poorly understood, although the introduction of newly 
developed animal models have greatly increased the 
understanding of oral motor control (Ellison et al, 
1987; Koshikawa et al. 1989; Prinssen et aL 1992).
In the cat it has been shown that OFD can be elicited 
by stimulating dopamine receptors within the 
anterodorsal part of the caudate nucleus (Cools et ah 
1976; Spooren et al. 1991a). This part of the caudate 
nucleus (CN) is predominantly innervated by the cell 
group A8 and is characterized by a relatively low con­
tent of striosomes (Desban et al. 1989; Spooren et al, 
1991a). OFD in the cat is also elicited from the first 
order output station of the CN, i.e. a circumscribed 
(enkephalin rich) part of the subpallidal area (SP; Cools 
et al. 1989a, b; Spooren et al. 1989; 1991b). Moreover, 
it has been shown that striatally-induced OFD can be 
blocked at the subpallidal level (SP), indicating that 
effects elicited from the CN are funneled through sub­
pallidal structures (Spooren et al. 1991a).
Using Phaseolus vulgaris leucoagglutinin (PHA-L) 
as an anterograde tracer, we have recently shown that 
the dorsomedial part of the subthalamic nucleus and 
the adjoining lateral hypothalamic area (STH) receive 
a massive input from the OFD-sensitive subpallidal
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region (SP; Spooren et al. 1993). The relationship of 
the subpallidal regions with the subthalamic nucleus is 
reciprocal in rat and monkey (rat: Berendse and 
Groenewegen 1990; monkey: cf. Russchen et al. 1985;
Smith et al. 1990; Haber et al 1993). Until recently, 
the subthalamic nucleus was thought to exert an 
inhibitory effect on the basal ganglia, but this view has 
changed dramatically over the last few years. It is 
accepted now that the output neurons of the subthal­
amic nucleus use glutamate as a neurotransmitter and 
exert a general excitatory influence upon their targets, 
among others the pallidal complex, and thus act as a
“driving force55 of the basal ganglia (Smith and Parent --------------------
1988; Albin et al. 1989; Bergman et ah 1990; Robledo Materials and methods
and Feger 1990; Brötchie and Crossman 1991). In addi­
tion, recent data have indicated that subthalamo-pall- Subjects and surgical procedures
chosen in view of the fact that stimulation of 
GABAergic transmission in the SP is known to atten­
uate OFD elicited from the SP (Spooren et al. 1991a). 
To answer the second question, we investigated to what 
extent bilateral injections of the GABAa agonist MSM 
into the STH could inhibit the OFD elicited by PTX 
injections into the SP. The rationale for using the 
GABA agonist was two-fold: (a) the pallido-subthal- 
amic pathway is GABAergic (see above), and (b) this 
drug was found to attenuate OFD elicited from the 
STH (outcome first series of experiments).
idal and striato-pallidal projections converge onto the 
same pallidal neuron, having resulted in the hypothe­
sis that the functional state of each pallidal neuron is 
determined by a complex interplay of excitatory and 
inhibitory inputs originating from subthalamic and 
striatal neurons, respectively (Hazrati and Parent 1992; 
Parent and Hazrati 1993; cf. Turski et al. 1990; Ryan 
and Clark 1991).
In view of these and other findings (see also: 
Crossman et al. 1984; Crossman 1987), the question 
arose to what extent the STH is involved in the con­
trol and/or expression of the OFD that originates in 
the CN and is funneled to the SP. The first series of 
experiments was devoted to the question whether the 
STH itself is involved in OFD. For that purpose, bilat­
eral injections of the non-competitive GABA antago­
nist picrotoxin (PTX) were administered into the STH 
of freely moving cats. This drug was chosen in view of 
the fact that the major input to the STH is known to 
be a GABAergic projection from pallidal structures 
(Kimetal. 1976; Fonnumetal. 1978; Rouzaire-Dubois 
et al. 1980; Carpenter et al. 1981a, b). The behaviour 
was qualitatively and quantitatively analyzed in terms 
of numbers of the movements of the tongue, ear, eye­
lid and cheek. To establish the GABAergic nature of 
the PTX effects, two sets of experiments were per­
formed: (a) a dose-effect curve was constructed, and 
(b) the ability of the GABAa agonist muscimol (MSM) 
to attenuate the PTX effects was investigated. Following 
the finding that the STH is indeed involved in the dis­
play of OFD, it was investigated (a) whether the OFD 
elicited from the STN needs the SP for its expression, 
and (b) whether the OFD elicited from the SP needs 
the STN for its expression. To answer the first ques­
tion, we investigated to what extent bilateral injections 
of the glutaminergic antagonist kynurenic acid (KYN) 
or the GABAa agonist MSM into the SP could inhibit 
the OFD elicited by PTX injections into the STH. The 
glutamate antagonist was chosen in view of the fact 
that the transmission in the subthalamo-pallidal path­
way is mediated by an excitatory amino acid, proba­
bly glutamate (see above). The GABA agonist was
Male cats (// = 22; age 12-13 months; Animal Laboratory, 
University of Nijmegen) weighing 3.5-5.4 kg were used. Each 
group, composed of seven or eight cats, was housed in a cage 
(2 x 3 x 2 m) with water and food available ad libitum and treated 
according to the (ethical) guidelines of the Dutch law on labora­
tory animals. Under deep anaesthesia [40 mg/kg pentobarbital 
(Narcovet, intraperitoneally; Apharmo, The Netherlands)] the ani­
mals were stereotaxically equipped with stainless steel guide can- 
nulae (inner diameter and outer diameter 0.55 and 0.8 mm, 
respectively) aimed at the sub-pallidal area (SP: coordinates A 15.0, 
L 5.3, H —2.5, a lateral 7.0°, a caudal 5.0°; Snider and Niemer 
1964) and/or the medial subthalamic nucleus and adjoining lateral 
hypothalamic area (STH; coordinates A 8.0, L 3.4, I i  —4.0; Snider 
and Niemer 1964), In order to avoid unnecessary damage to the 
target site, the carinulae were placed 2 mm above the target region.
Apparatus
Cats were tested in a soundproof observation cage (90 x 60 x 60 cm) 
with a Plexiglas front panel. The cage was equipped with two 
ventilators which produced a constant background noise.
Experimental procedures
After recovering from the operation for a minimum period of 3 
days, the cats were placed in the observation cage to habituate them 
to the cage and to the experimental procedures (see below; each cat
3 x 1 h sessions on successive days). During the last habituation 
session the cats received a bilateral “dummy” injection. The 
experiments started after a minimum period of 7 days following the 
operation.
On the test day the cat was placed in the observation cage and 
allowed to rehabituate for a period of 15 min. The recording of the 
behaviour started immediately at the end of this period. The behav­
iour was recorded with the help of a closed circuit TV and stored 
on videotape for off-line analysis. The presence of ovo-facial dysk­
inesia was detected by analyzing the nature of movements of the 
ear, eyelid, cheek and tongue. Oro-facial dyskinesia was quantita­
tively analyzed by counting the number of tongue protrusions which 
are known to signal the end of an OFD attack (Cools et al. 1989a). 
The experiment itself was divided into two parts by the injections: 
a pre-injection period of 15 min and a post-injection period of 
45 min, The pre-injection period was used to discard animals that 
displayed abnormal tongue protrusions as a consequence of previ­
ous treatments. Since this only occurred in cats that received more 
than six drug treatments, the number of treatments was limited to 
six (Cools et al. 1989a). When cats received injections into different
22
structures, the injections known to elicit OFD were given immedi­
ately after the injections expected to attenuate OFD. All injections 
were given with a Hamilton syringe (5 jal; sharpened tip). The nee­
dle was lowered 2 mm below the end of the cannula in order to 
reach the chosen target site (see above). The injection itself lasted
15 s whereas the needle was kept in place for another 10 s.
'
Experiment 1
In this experiment eight cats equipped with cannulae directed 
towards the STH were used. They received the following bilateral 
injections: solvent, picrotoxin (PTX (Serva, Heidelberg, Germany): 
250, 500, 50 and 150 ng, subsequently), muscimol (MSM (Serva, 
Heidelberg, Germany): 50 ng) and the combination PTX (250 ng) 
and MSM (50 ng) in a cocktail.
Experiment 2 and 3
In these experiments nine cats equipped with cannulae directed 
towards the STH and SP were used. They received bilateral injec­
tions of the following combination of drugs (SP-STH): solvent- 
solvent, solvent-PTX (250 ng), MSM (100 ng)-PTX (250 ng), PTX 
(500 ng)-solvent, PTX (500 ng)-MSM (50 ng) and kynurenic acid 
(KYN (Sigma, St Louis, USA): 1000 ng)-PTX (250 ng). An addi-
i on a 1 group of five cats were used to determine the effects of KYN 
injections alone into the SP. All drugs were dissolved in sterile dis­
tilled water (NPBI, The Netherlands), except for KYN which was 
dissolved in 1 N NaOH (pH correction and set on 7.4). All drugs 
were injected in a volume of 0.5 jwl.
Fig. 1 The distribution of the injections sites in the STH from 
rostral (top) to caudal (bottom) levels of the cats used in experi­
ment 1. One dot represents one injection site whereas all injection 
sites are represented on one side of the brain. Abbreviations: STN 
nucleus subthalamicus, LHA lateral hypothalamic area
Histological evaluation
At the end of the experiments the cats were deeply anaesthetized 
with pentobarbital (60 mg/kg, intraperitoneally) and transcardially 
perfused with saline followed by a 4% paraformaldehyde solution. 
The brains were removed and subsequently cut on a freezing micro­
tome in sections of 30 |im, The sections were stained for cresyl 
violet in order to estimate the location of the injection site.
Statistics
An overall Friedman two-way ANOVA was performed, followed 
by the Wilcoxon matched-pairs signed-ranks test (two tailed) or the 
Mann-Whitney U test (two-tailed). The latter was used in the case 
of independent groups design which only existed in the compari­
son of KYN injections alone (for which we used an additional group 





Histological evaluation revealed that all injection sites 
were correctly placed into the target region of the STH 
as determined by the afferent input from the OFD- 
sensitive part of the sub-pallidal area [SP; Fig. 1 
(cf. Spooren et al, 1993b)].
Picrotoxin (PTX) in the dose range 50-250 ng elicited 
a full-blown oro-facial dyskinetic syndrome which con­
sisted of sudden attacks of tic-like contractions involv­
ing the ear, eyelid and cheek which were accompanied 
by tongue protrusions. The tongue protrusions were 
abnormal and consisted of curling upwards the lateral 
sides of the tongue and protruding the curled tongue 
via the left or right corner of the mouth, or curling the 
tip of the tongue upwards and inwards against the pala­
tum and then protruding it or pressing the tip of the 
tongue against the irmerside of the cheek and then pro­
truding it. Similar combinations of movements were 
previously seen in cats with OFD elicited from the 
anterodorsal caudate nucleus or the SP (Cools et al. 
1976, 1989a). At the highest injected dose of PTX 
(500 ng) a combination of immobility and explosive 
motor activity was elicited. Seizures did not occur. For 
the longestpart of the observation the cats remained in 
a fixed position (immobile), standing, sitting or in a 
position between these two extremes. All animals had 
a trunk torsion, and their heads were either turned to 
a lateral side (lateral torticollis) or turned backwards 
(retro-torticollis). These positions were suddenly inter­
rupted by moments of jumping and falling of the ani­
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Fig. 2 Median value of the number of tongue protrusions in 45 min 
following bilateral injections of control [distilled water 
(.PTXIMSM : O/O)], picrotoxin (PTX\ 50, 150, 250 and 500 ng), 
muscimol (MSM; 50 ng) and the combination picrotoxin (PTX 
250 ng) and MSM (50 ng) into the STH; bars in histograms rep­
resent the interquartile range (25-75%). Statistics: [Overall 
(0-500 ng PTX): Friedman two-way ANOVA (%2(4) = 9.5, 
^  < 0.05)]; (drug/dose specific comparison) Wilcoxon matched 
pairs signed ranks test, *P< 0.05, **P<0.02, ***P<0.01. (ng 
nanogram)
during which the corners of the mouth were pulled 
towards the ears. Only an incidental single burst of 
OFD was seen in these cats.
Quantitative effects
Dose-response relation. Bilateral injections of PTX (50, 
150, 250 ng/0.5 |il) elicited a significant and dose- 
dependent increase in the number of tongue protru­
sions. The most effective dose was 250 ng, whereas a 
dose twice as high lost its efficacy [(0-500 ng PTX): 
Friedman two-way ANOVA (x2(4) = 9.5, P<0.05)]; 
a bell-shaped dose-response relation was the result
(Fig. 2).
GAB A specificity.  The most effective dose of PTX 
(250 ng) was selected to determine GABA specificity: 
the number of tongue protrusions elicited by 250 ng 
PTX was significantly attenuated by 50 ng muscimol, 
i.e. a dose which itself had no effect (Fig. 2).
Experiments 2 and 3 
Histological clata
Histological evaluation revealed that all injection sites 
were correctly placed into the target region of the SP 
(Fig. 3a) and the STH (Fig. 3b).
Fig. 3 The distribution of the injection sites in the SP (a) and the 
STH (b) of the cats used in experiments 2 and 3. One dot repre­
sents one injection site whereas all injection sites are represented 
on one side of the brain. Abbreviations: CA anterior commissure, 
CD caudate nucleus. C l internal capsule, GP globus pallidus, PU 
putamen, SCGP subcommissural part of the globus pallidus, SI 
substantia innominata
Involvement of glutamate and lor GÀBÀ in the SP 
following OFD elicited from the STH
PTX (250 ng) injected into the STH elicited a 
significant increase in the number of tongue protru­
sions (as described above; Fig. 4), This effect was in 
turn significantly attenuated by local injections of 
1000 ng kynurenic acid (KYN), i.e. a dose which had 
no effect itself (Fig. 4), into the SP. In contrast, local 
injections of 100 ng MSM into the SP had no effect on 
the OFD elicited by 250 ng PTX in the STH.
Role of STH in GABA-mediated OFD in the SP
PTX (500 ng) injected into the SP, as outlined previ­
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Fig. 4 Median value of the number of tongue protrusions in 45 min 
following bilateral injections of various drugs into the SP [musci­
mol (MSM)i kynurenic acid {KYN) or their solvent (C)] and the 
STH [pierotoxin (PTX) or its solvent (C)];bars in histograms rep* 
resent the interquartile range (25%—75%). Statistics: Wilcoxon 
matched pairs signed ranks test, *P< 0.05, **? < 0.02, ***ƒ>< 0.01 
(KYN injections alone were compared using the Mann-Whitney U 
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600 ng PTX 
GO ng MSM
Fig. 5 Median value of the number of tongue protrusions in 45 min 
following bilateral injections of drugs into the SP [picrotoxin (PTX)] 
and the STH [muscimol (MSM)] or their solvent (C); bars in his- 
tograms represent the interquartile range (25-75%), Statistics: 
Wilcoxon matched pairs signed ranks test, *P < 0.05, **P < 0.02, 
***ƒ> < o,01. ng nanogram
resulted in a significant increase in the number of 
tongue protrusions (Fig, 5). This effect was in turn 
significantly attenuated by local injections of 50 ng 
MSM, i.e. a dose which had no effect itself (Fig. 2), 
into the STF1 (Fig. 5).
Discussion
This study investigated the involvement of the medial 
part of the subthalamic nucleus and the adjoining
lateral hypothalamic area (STH) in oro-facial dyskine­
sia (OFD) and the interaction of the STH with the 
OFD-sensitive subpallidal area (SP) in the cat, The 
main findings are detailed below.
First, the quali tative analysis of the behaviour elicited 
by local injections of low doses (50-250 ng/ 0.5 jul) of 
the non-competitive GABA antagonist picrotoxin 
(PTX) into the STH showed that the STH is involved 
in the display of OFD. The more lateral parts of the 
subthalamic nucleus were not investigated in the pre­
vent study. However, since these parts of the nucleus do 
not receive input from the OFD-specific region of the 
SP (Spooren et aL 1993b), which is densely enkephalin 
immunoreactive (Cools et al. 1989b; Spooren et al. 
1989) but also contains substance-P immunoreactive 
elements (cf. Groenewegen and Russchen 1984), it is 
unlikely that OFD is elicited from these parts of the 
subthalamic nucleus. The OFD seen in the present study 
did not differ from that seen in earlier studies on the 
involvement of the CN and the SP in OFD (Cools 
etal. 1989a; Spooren et al. 1991a, b). A quantitative 
analysis of the observed OFD showed that the effect 
was dose-dependent (50-250 ng). The observation that 
the highest dose of PTX (500 ng) induced a fully 
different syndrome, namely a combination of immobil­
ity and explosive motor activity, may indicate that the 
di ffusion of PTX was no longer limited to the area under 
investigation. The GABAa agonist muscimol (MSM) 
was found to attenuate significantly the OFD elicited 
by the most effective dose of PTX (250 ng), whereas 
MSM alone did not produce any change in this respect. 
These data together show that the OFD under study 
was GABA specific. Thus, it is concluded that inhibi­
tion of GABA in the STH gives rise to OFD in the 
cat. Given the inhibitory nature of GABA, the present 
data imply that neurons of the STH are under inhibitory 
control of GABA under normal conditions. Since the 
STH receives a massive GABAergic input of the SP, it 
is most likely that the SP exerts this inhibitory control 
upon the STH. Previously it was shown that removal 
of the inhibitory control of GABA in the SP also results 
in OFD (Cools et al. 1989a, b). Combining both sets 
of data results in the notion that the removal of the 
inhibitory control by GABA in the SP did not disin- 
hibit the GABAergic pallido-subthalamic pathway. 
Such a disinhibition would have led to an enhanced 
release of GABA in the STH which per se inhibits OFD 
(see below). Given the finding that enhancing the 
GABA activity in the SP prevents OFD elicited from 
the CN, it appears that the inhibitory control of GABA 
in the SP is exerted upon cells receiving a striatal 
input and not upon cells giving rise to the subpallido- 
subthalamic output. In any event, the available 
data show that OFD is under control of GABA in at 
least two distinct territories, i.e. subpallidal and 
subthalamic territories (cf Gunne et al. 1984).
Second, the OFD effect of picrotoxin (250 ng) 
injected into the STH was significantly attenuated and
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in fact completely blocked by injections of the broad 
spectrum glutamate antagonist kynurenic acid (KYN; 
1000 ng), but not by the GABA agonist muscimol 
(MSM; 50 ng) into the SP. From these data it can be 
concluded that a) OFD elicited from the STH needs 
the SP for its expression and that b) this expression 
involves glutaminergic, but not GABAergic, transmis­
sion in the SP (see also below). Since the transmission 
of the subthalamo-pallidal pathway is mediated by an 
excitatory amino acid, probably glutamate (see intro­
duction), it is likely that removal of this excitatory input 
underlies the suppression of OFD elicited from the 
STH. It was already known that enhancing the 
inhibitory control by GABA in the SP suppresses OFD 
elicited from the CN (Spooren et al. 1991a). In other 
words, there appears to exist a delicate glutamate- 
GABA balance in the SP that controls the presence or 
absence of OFD. The data also suggest that, apart from 
dopamine and GABA, glutamate too plays a role in 
the aetiology of OFD (cf. Andren and Gunne 1992).
Third, the OFD effect elicited by 500 ng picrotoxin 
injected into the SP was significantly attenuated by 
50 ng muscimol injected into the STH. From these 
data it is concluded that a) OFD elicited from the SP 
needs the STH for its expression, and that b) this 
expression involves GABAergic transmission in the 
STH. Since the major input to the STH is a GABAergic 
projection from pallidal structures, it is likely that acti­
vation of this inhibitory input underlies the suppres­
sion of OFD elicited from the SP.
The present study shows that OFD is funneled along 
the pallidal-subthalamic-pallidal pathway and that, at 
least at this level of the brain, OFD remains within the 
boundaries of basal ganglia structures. However, the 
behavioural expression of this basal ganglia related dis­
order also involves participation of structures that are 
selectively innervated by basal ganglia regions. We 
recently have investigated the output structures of the 
SP which has led to the finding of several possible tar­
gets that may funnel the OFD from the SP to lower 
brain structures (Spooren 1992; Spooren et al. 1991c, 
1993a, b). These include the lateral habenula nucleus, 
the central nucleus of the amygdala and the peripedun- 
cular nucleus (Spooren 1992; Spooren et al. 1993a, b; 
unpublished observations). Recently we have shown 
that the peripeduncular nucleus is involved in oral 
motor control, but that this nucleus is not involved in 
the display of OFD (Spooren et al. 1993a). At present 
it is not clear along which neural circuits OFD is 
funneled.
In conclusion, the present study shows that inhibi­
tion of GABA in the STH induces OFD in the cat. 
This OFD effect needs the SP for its expression and is 
mediated via glutaminergic, but not GABAergic, neu­
rotransmission. This study also shows that the OFD 
which is elicited from the SP needs the STH for its 
expression. This OFD effect is mediated via a 
GABAergic process in the STH.
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